Ulti_1170x120_5-11-20

Rite Aid opens new COVID-19 testing sites in Michigan and Ohio

Print Friendly, PDF & Email

Now operating 264 testing sites in 15 states.

CAMP HILL, Pa.Rite Aid continues to expand its no-charge COVID-19 testing service with the addition of six drive-through locations opening on July 30 in Michigan and Ohio, through its partnership with the U.S. Department of Health and Human Services (HHS).

Like Rite Aid’s existing drive-through testing sites, the new locations will utilize self-swab nasal tests overseen by Rite Aid pharmacists, and will operate Monday through Friday 10 a.m. – 8 p.m. and Saturday and Sunday 10 a.m. – 5 p.m.

Rite Aid’s COVID-19 nasal tests are available for all adults, regardless if they are experiencing virus symptoms, in accordance with the Centers for Disease Control and Prevention (CDC) guidance. At all testing locations, patients are required to provide government issued identification, be at least 18 years old and need to pre-register online at www.riteaid.com in order to schedule a time slot for testing.

Now operating 264 testing sites in 15 states, Rite Aid will have the capacity to conduct more than 96,100 tests weekly across all locations.

The six new testing sites are located at the following Rite Aid stores:

– 4410 South Division Street in Kentwood, Mich.
– 2410 Burton Street SE in Grand Rapids, Mich.
– 6512 Franklin Blvd in Cleveland, Ohio
– 5411 Superior Ave in Cleveland, Ohio
– 10090 Chester Ave in Cleveland, Ohio
– 3402 Clark Ave in Cleveland, Ohio

A complete list of Rite Aid’s COVID-19 testing sites can be found at www.riteaid.com

Rite Aid partners with Verily and its Baseline COVID-19 Testing Program to provide screening, scheduling and return of results to participants for Rite Aid testing sites. BioReference Laboratories provides COVID-19 laboratory testing.

Clinical oversight for the COVID-19 testing program is provided by PWNHealth, a national clinician network that enables safe and easy access to diagnostic testing.

Rite Aid will continue to provide regular updates on the company’s progress with COVID-19 testing.


NT_728x90_10-3-18

FREUD_728x90_6-19-20

Comments are closed.